Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ellerton

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
American Journal of Clinical Oncology|February 24, 2001
Phase II study of intravenous CI-958 in metastatic colorectal adenocarcinomaP M Hoff, J A Ellerton, S R Dakhil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancerGregory A Otterson, Miguel A Villalona-Calero, William Hicks, et al.
The New England Journal of Medicine|May 5, 1994
Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinomaW C Wood, D R Budman, A H Korzun, et al.
Journal for Immunotherapy of Cancer|October 10, 2020
Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysisAndrea B Apolo, John A Ellerton, Jeffrey R Infante, et al.
European Urology Oncology|July 13, 2023
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily IrradiationDouglas M Dahl, Theodore G Karrison, M Dror Michaelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2024
SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian CancerYoung Kwang Chae, Megan Othus, Sandip Pravin Patel, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
American Journal of Clinical Oncology|February 24, 2001
Phase II study of intravenous CI-958 in metastatic colorectal adenocarcinomaP M Hoff, J A Ellerton, S R Dakhil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancerGregory A Otterson, Miguel A Villalona-Calero, William Hicks, et al.
The New England Journal of Medicine|May 5, 1994
Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinomaW C Wood, D R Budman, A H Korzun, et al.
Journal for Immunotherapy of Cancer|October 10, 2020
Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysisAndrea B Apolo, John A Ellerton, Jeffrey R Infante, et al.
European Urology Oncology|July 13, 2023
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily IrradiationDouglas M Dahl, Theodore G Karrison, M Dror Michaelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2024
SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian CancerYoung Kwang Chae, Megan Othus, Sandip Pravin Patel, et al.
Pageof 2